Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)

NCT04623099 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Anxiety

Interventions

DRUG: Escitalopram

Sponsor

University of Cincinnati

Collaborators

[object Object]